Background In recent years, there has been rapid growth in pharmaceutical spending in
China. In addition, the country faces many challenges with regards to the quality, pricing and …

The rapid rise in pharmaceutical costs in France has been driven by new technologies and
the growing prevalence of chronic diseases as well as considerable prescribing freedom …

Objective: The objective of this paper is to analyze which pharmaceutical policies European
countries applied during the global financial crisis. Methods: We undertook a survey with …

Introduction To effectively regulate and reduce antibiotic use, in the livestock sector, a
thorough understanding of the flow of veterinary antibiotics will help to identify key nodes in …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

New technologies, including pharmaceuticals and medical devices, can improve treatment
options in healthcare but also bring concerns about rising healthcare costs. We undertake a …

It is a challenge to improve public health within limited resources. Pharmaceutical policy
making is a greater challenge due to conflicting interests between key stakeholder groups …

Background Paediatric outpatient prescription (POP) monitoring is pivotal to identify
inadequate prescriptions and optimize drug use. We aimed at describing recent trends in …

China has a complex pharmaceutical system that is currently undergoing significant reforms.
This book provides a comprehensive overview of China's pharmaceutical system and covers …

The main objective of this comparative analysis was to assess regulations applied by EU
governments to reward potentially innovative drugs. We focused on the pharmaceutical …